Inquiry Basket
Loading ......
Severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) infection has emerged as a worldwide threat, and numerous vaccines and immune tests have been developed and proposed to assess immune responses. In the case of the available diagnostic and research assays, severe acute respiratory syndrome coronavirus type 2 IgG ELISA kit has been the mainstay of immune response evaluation for natural infections and vaccine evaluation. SARS-CoV-2 IgG ELISA kit is designed to detect and quantify IgG antibodies against SARS-CoV-2 virus in human serum or plasma specimens, which can provide valuable information for vaccine immunogenicity, epidemiological investigation, and immune memory evaluation.
Figure 1. Schematic representation of SARS-CoV-2 replication cycle in host cells. (Santos, Igor de Andrade, et al. 2020)
Coronaviruses (CoVs) are a family of viruses from the Coronaviridae family that infects humans and other animals and can cause from mild to lethal diseases. As the world is currently fighting a pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), there is an urgent need for the development of new strategies for combatting the virus. Coronavirus (CoV) was first isolated in 1960 and identified as a coronavirus. It is an enveloped single-stranded RNA virus with a size between 25 and 32 kb. The virus's basic structure consists of structural spikes (S), membrane (M), envelope (E), and nucleocapsid (N) proteins. The M and E proteins are embedded in a viral envelope, a lipid bilayer that is derived from the host cell membrane. The N protein binds to viral RNA and is located in the core of viral particles.
Figure 2. Schematic structure of SARS-CoV-2. (Santos, Igor de Andrade, et al. 2020)
Respiratory droplets and contact transmission are the two primary ways in which novel coronavirus is transmitted. Droplets generated by patients sneezing and talking transmit the virus, and when vulnerable people inhale the droplets, they contract the infection. The droplets of saliva fall on the surface of the ground, get in touch with the mucous membranes of the mouth, nose, and eyes, and enter the respiratory tract to result in infection. There may be aerosol transmission in a semi-enclosed environment when there is prolonged exposure to a high concentration of virus aerosols. Since the novel coronavirus can be detected in feces and urine, fecal oral transmission is a possibility that should be taken seriously. Attention should also be paid to aerosol or contact transmission as a result of feces and urine in the pollution of the surrounding environment. The infection can be produced by contact with virus-contaminated items; thus, caution should be taken to the possibility of contact transmission and spread of cold chain items, general commodities, and so on.
| Importance | Description |
| SARS coronavirus as a coronavirus vaccine model | The research on SARS coronavirus vaccine is still relevant for several reasons: Prevention of epidemics: The lessons and immune response to the severe acute respiratory syndrome coronavirus infection are useful in predicting future coronavirus epidemics and providing information for the development of vaccine strategies for future coronavirus infections. Cross protection study: The SARS coronavirus vaccine may produce antibodies that are also able to recognize SARS-CoV-2, which can be used to predict the cross-protection and cross-neutralization ability of vaccines and understand the mechanisms of cross-protective immunity and provide new directions for the development of pan coronavirus vaccines. Mechanism insight: The spike (S) protein of the SARS coronavirus is structurally similar to other coronaviruses, which makes it a good choice for antibody-mediated neutralization experiments that can be used to reveal the neutralization mechanism of antibodies against SARS-CoV-2. |
| Why ELISA is crucial for vaccine immunogenicity testing | In contrast to neutralization tests like PRNT or pseudovirus neutralization, ELISA has some advantages, including: ✔ High throughput - 96-384 samples can be processed per run, which is very suitable for large-scale vaccine studies. ✔ Quantitative data - Quantitative and can provide the exact IgG concentration (IU/mL or OD value) for dose-response curve. ✔ Cost effectiveness - The cost per sample is 50-70% less than that of cell-based neutralization tests. |
SARS-CoV-2 IgG ELISA kit is a semi quantitative or quantitative immunoassay that uses enzyme-linked immunosorbent assay (ELISA) technology to identify SARS-CoV-2 virus specific IgG antibodies. These kits are used mainly in research labs to assess the immunogenicity of vaccines, track the evolution of immune responses, and to evaluate the efficacy of various vaccine candidates. Most of these kits are for research use only (RUO) and not for clinical diagnosis.
SARS-CoV-2 IgG ELISA kit has a broad range of application, especially for vaccine development:
During vaccine clinical trials, test kits are used to evaluate the humoral immune responses produced by different candidate vaccines. This includes evaluating serum conversion rate (the proportion of individuals who produce detectable antibodies after vaccination), the degree of antibody response, and the duration of immunity. The data from these tests is crucial for determining the effectiveness and safety of vaccines.
This kit can be used to monitor the spread of severe acute respiratory syndrome coronavirus type 2 by evaluating the serum prevalence of different populations. This is particularly useful in low-income countries with limited diagnostic resources.
This kit can be used in animal models to study immune responses to severe acute respiratory syndrome coronavirus type 2. It can also be used to detect cross species transmission of viruses.
Our SARS-CoV-2 detection kit supports the entire detection cycle of the virus. Built with our proprietary detection chemistry and innovative antibody pairs, our kits exhibit excellent sensitivity and extremely low cross reactivity, providing accurate and reliable data even in the most challenging samples. The following are the main products:
| ELISA Kit | Application |
| SARS Coronavirus IgG ELISA Kit | Intended for the qualitative determination of the class IgG antibodies against SARS Coronavirus in Human serum or plasma. It can be used for the diagnosis and monitoring of patients related to infection by SARS Coronavirus. |
| Mouse Anti-SARS-CoV-2 IgG1 ELISA Kit | This product is mainly used for in vitro quantitative detection of anti-SARS-CoV-2 IgG1 antibodies in mouse serum, plasma and other culture samples. It can be used to detect the amount of IgG1 antibodies produced by mouse after immunization or mouse IgG1 antibodies expressed in cell culture. |
| SARS-CoV-2 IgG ELISA Kit | This SARS-CoV-2 lgG seroconversion assay is mainly intended for the qualitltNe detection of SARS-CoV-2 specific antibocles of isotype lgG in human serum. |
Robustness and Repeatability
The standardized ELISA detection also contributes to robustness and repeatability, which means that the same results will be obtained when repeated testing is carried out in similar circumstances.
Cost effectiveness
Compared to more complicated and expensive methods, for example virus neutralization tests, ELISA is a relatively cost-effective antibody detection approach, allowing it to be available for a wider range of research and public health applications.
Mature Methodology
ELISA is also a mature and well-accepted laboratory method with a long track record of usage in immunology and infectious disease diagnosis. This familiarity allows it to be more easily adopted and understood by the scientific community.
The SARS coronavirus IgG ELISA kit is a very useful and essential tool for the global battle against SARS-CoV-2. Its capacity to precisely and quantitatively measure the vaccine induced IgG antibody response is critical in the efforts to develop and evaluate vaccines, and in supporting decisions on vaccine development, allocation, and immunization. As more research is completed into the complexity of the immunity against SARS-CoV-2, dependable immunogenicity testing will also continue to play a major role in the battle to maintain public health.
Reference
Loading ......
